Vimarsana
Biggest News Aggregation in the World

Page 8 - Prosight Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prosight Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prosight Management Today - Breaking & Trending Today

Boston Partners Buys 1,611,891 Shares of R1 RCM Inc. (NASDAQ:RCM) - Vimarsana News

Boston Partners Buys 1,611,891 Shares of R1 RCM Inc. (NASDAQ:RCM)

Boston Partners lifted its stake in R1 RCM Inc. (NASDAQ:RCM – Get Rating) by 204.0% in the 4th quarter, Holdings Channel reports. The institutional investor owned 2,402,194 shares of the healthcare provider’s stock after acquiring an additional 1,611,891 shares during the period. Boston Partners’ holdings in R1 RCM were worth $27,508,000 as of its most […]

Source: wkrb13.com
Galapagos (NASDAQ:GLPG) Shares Gap Down to $41.00 - Vimarsana News

Galapagos (NASDAQ:GLPG) Shares Gap Down to $41.00

Galapagos NV (NASDAQ:GLPG – Get Rating) shares gapped down before the market opened on Wednesday . The stock had previously closed at $41.00, but opened at $39.63. Galapagos shares last traded at $39.39, with a volume of 133,932 shares trading hands. Wall Street Analyst Weigh In A number of brokerages have recently weighed in on […]

169,301 Shares in R1 RCM Inc. (NASDAQ:RCM) Acquired by EFG Asset Management North America Corp. - Vimarsana News

169,301 Shares in R1 RCM Inc. (NASDAQ:RCM) Acquired by EFG Asset Management North America Corp.

EFG Asset Management North America Corp. bought a new position in R1 RCM Inc. (NASDAQ:RCM – Get Rating) in the fourth quarter, Holdings Channel reports. The firm bought 169,301 shares of the healthcare provider’s stock, valued at approximately $1,850,000. Other institutional investors also recently bought and sold shares of the company. Texas Permanent School Fund […]

Source: wkrb13.com
Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target Lowered to $81.00 at Raymond James - Vimarsana News

Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target Lowered to $81.00 at Raymond James

Mirum Pharmaceuticals (NASDAQ:MIRM – Get Rating) had its target price trimmed by Raymond James from $83.00 to $81.00 in a research report sent to investors on Thursday morning, The Fly reports. Several other analysts also recently commented on the stock. HC Wainwright reissued a buy rating and set a $61.00 price objective on shares of […]

Brokerages Anticipate NeoGenomics, Inc. (NASDAQ:NEO) Will Post Earnings of -$0.20 Per Share - Vimarsana News

Brokerages Anticipate NeoGenomics, Inc. (NASDAQ:NEO) Will Post Earnings of -$0.20 Per Share

Wall Street brokerages expect that NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) will report earnings of ($0.20) per share for the current quarter, Zacks Investment Research reports. Five analysts have issued estimates for NeoGenomics’ earnings, with the highest EPS estimate coming in at ($0.18) and the lowest estimate coming in at ($0.21). NeoGenomics reported earnings of […]